Susquehanna International Group, LLP Verrica Pharmaceuticals Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 28,162 shares of VRCA stock, worth $223,887. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,162

Previous 19,847 41.9%

Holding current value

$223,887

Previous $144,000 54.86%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.95 - $7.95 $66,104 - $66,104	8,315 Added 41.9%	28,162 $223,000
Q2 2024 Aug 15, 2024	BUY	$5.89 - $9.56 $116,898 - $189,737	19,847 New	19,847 $144,000
Q4 2023 Feb 14, 2024	BUY	$2.93 - $7.32 $62,039 - $154,993	21,174 Added 168.62%	33,731 $246,000
Q3 2023 Nov 14, 2023	SELL	$3.75 - $7.46 $145,402 - $289,254	-38,774 Reduced 75.54%	12,557 $48,000
Q2 2023 Aug 11, 2023	SELL	$5.32 - $6.79 $451,359 - $576,077	-84,842 Reduced 62.3%	51,331 $296,000
Q1 2023 May 16, 2023	BUY	$2.88 - $8.51 $261,757 - $773,456	90,888 Added 200.7%	136,173 $885,000
Q4 2022 Feb 14, 2023	BUY	$2.09 - $3.39 $21,493 - $34,862	10,284 Added 29.38%	45,285 $124,000
Q3 2022 Nov 14, 2022	BUY	$2.17 - $4.3 $44,257 - $87,698	20,395 Added 139.63%	35,001 $102,000
Q2 2022 Aug 15, 2022	BUY	$1.81 - $8.93 $26,436 - $130,431	14,606 New	14,606 $28,000
Q4 2021 Feb 14, 2022	SELL	$9.1 - $13.36 $512,129 - $751,874	-56,278 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.55 - $13.96 $421,155 - $615,636	44,100 Added 362.13%	56,278 $703,000
Q2 2021 Aug 11, 2021	SELL	$9.77 - $15.33 $6,076 - $9,535	-622 Reduced 4.86%	12,178 $138,000
Q1 2021 May 17, 2021	BUY	$10.51 - $17.46 $134,528 - $223,488	12,800 New	12,800 $194,000

Others Institutions Holding VRCA

# of Institutions

Shares Held

14.2M

Call Options Held

9.9K

Put Options Held

6.5K

View Full List

About Verrica Pharmaceuticals Inc.

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

More about VRCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Verrica Pharmaceuticals Inc. Transaction History